New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 22, 2013
13:39 EDTHLF, AVP, NUSNu Skin hits 52-week high after results, guidance top estimates
Shares of global direct selling company Nu Skin Enterprises (NUS) hit a new 52-week high after beating third quarter estimates and raising its full year guidance. WHAT'S NEW: This morning, Nu Skin reported Q3 EPS of $1.80 and revenue of $927.6M against analystsí consensus views of $1.41 and $798.2M. The company forecast Q4 EPS of $1.85-$1.90, and revenue of $1.02B-$1.05B. Analystsí consensus estimates were $1.63 and $899.1M, respectively. The company raised it fiscal 2013 guidance for both sales and profit. Nu Skin now expects to generate revenue of $3.18B-$3.21B this fiscal year, which is up from its prior view of $2.91B-$2.95B. WHAT'S NOTABLE: On the company's earnings conference call, CEO Truman Hunt previewed that on Thursday, at the company's global sales convention, Nu Skin will initiate a new long-term sales goal. The company will challenge its sales force to grow sales to $10B per year by 2020, according to Hunt, which compares to its prior $5 billion a year sales goal. PRICE ACTION: In afternoon trading, Nu Skin rose 5.3% to $108.14. Earlier in the session the stock made a fresh 52-week high of $119.46 and the stock is up nearly 200% year to date given today's advance. OTHERS TO WATCH: Others in the direct selling space include Herbalife (HLF), Avon Products (AVP) and Amway.
News For NUS;HLF;AVP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 30, 2014
06:41 EDTAVPAvon Products China bribery case dismissed, Reuters says
Subscribe for More Information
06:00 EDTAVPStocks with implied volatility movement; AVP TWTR
Subscribe for More Information
September 29, 2014
14:37 EDTAVPChina bribery suit against Avon Products dismissed, Reuters says
Subscribe for More Information
September 25, 2014
10:45 EDTNUSOptions with increasing implied volatility
Options with increasing implied volatility: VALE CLF NUS HLF SVXY VXX AGQ SQQQ
September 24, 2014
11:54 EDTHLFStocks with call strike movement; HLF PLUG
Subscribe for More Information
09:03 EDTHLFKyle Bass says Herbalife not Ponzi scheme, has no position now
Subscribe for More Information
08:59 EDTHLFKyle Bass says 'I believe FTC won't sue' Herbalife
Hayman Capital's Kyle Bass is speaking on CNBC.
September 23, 2014
16:20 EDTHLFOn The Fly: Closing Wrap
Stocks on Wall Street were lower after the U.S. took new action to clamp down on tax inversion deals and led airstrikes against Islamic State militants in Syria, while Europe reported weaker than expected manufacturing data. ECONOMIC EVENTS: In the U.S., the FHFA's home price index rose 0.1% in July to 212.7, missing expectations for an increase of 0.5%. Markit's preliminary manufacturing Purchasing Managers' Index for September came in at 57.9, slightly below the consensus forecast for a 58.0 reading. In China, HSBC's flash manufacturing PMI rose to 50.5 from a final reading of 50.2 in August, better than expectations. In Europe, Markit's composite flash PMI for the eurozone dipped to a nine-month low of 52.3, missing expectations for it to hold steady with its 52.5 reading for August. COMPANY NEWS: The shares of a number of companies that have announced or been speculated as targets in tax inversion deals fell after the U.S. Treasury last night issued new regulations that will make such deals less attractive. AstraZeneca (AZN), which has previously turned down an offer to be acquired by the U.S.'s Pfizer (PFE), sank $3.54, or 4.74%, to $71.13 despite a Bloomberg report that said Pfizer is still considering pursuing a deal with the U.K. drugmaker. AbbVie (ABBV), which has a deal in progress to acquire Shire (SHPG) and thus move its tax domicile to Ireland, fell $1.15, or 1.96%, to $57.56, while Shire shares slid $5.56, or 2.17%, to $250.74. Medtronic (MDT), which is pursuing its own inversion deal with Covidien (COV), dropped $1.90, or 2.88%, to $64.08. MAJOR MOVERS: Among the notable gainers was Herbalife (HLF), which rose $3.88, or 9.65%, to $44.09, bouncing back from a pullback yesterday that had been attributed to rumors of Carl Icahn selling out of his stake in the company. Also higher was Plug Power (PLUG), which rose 40c, or 9.57%, to $4.58 after the company's CEO gave FY15 revenue guidance that was above the consensus Street view in an interview with the Albany Business Review. Among the noteworthy losers was Ascena Retail (ASNA), which dropped $2.78, or 16.82%, to $13.75 after the apparel retailer's fourth quarter results and fiscal 2015 profit outlook trailed analysts' consensus estimates. Also lower were shares of used car retailer CarMax (KMX), which fell $5.01, or 9.49%, to $47.80 after the company reported sluggish comparable used car sales in its second quarter. INDEXES: The Dow declined 116.81, or 0.68%, to 17,055.87, the Nasdaq dropped 19.00, or 0.42%, to 4,508.69, and the S&P 500 fell 11.52, or 0.58%, to 1,982.77.
11:19 EDTHLF Options with increasing implied volatility
Options with increasing implied volatility: HLF VRTX TRP CLX ETP VALE
10:21 EDTHLFHerbalife options active on wide price movement
Subscribe for More Information
09:13 EDTHLFOn The Fly: Pre-market Movers
Subscribe for More Information
06:29 EDTHLFHerbalife volatility increases on pullback
Subscribe for More Information
05:49 EDTHLFStocks with implied volatility movement; HLF CMG
Subscribe for More Information
September 22, 2014
18:18 EDTHLFOn The Fly: After Hours Movers
Subscribe for More Information
18:12 EDTHLFHerbalife reverses in after-hours trading, up 2.6%
16:17 EDTHLFIcahn has not sold any of Herbalife position, Gasparino says
Carl Icahn has not sold out of his stake in Herbalife, according to sources close to the matter, reported Fox Business' Charles Gasparino on Twitter.
15:54 EDTHLFHerbalife drop attributed to rumor of Icahn liquidating stake, Kass says
Subscribe for More Information
15:52 EDTHLFHerbalife volatility spikes on wide price movement
Subscribe for More Information
15:46 EDTHLFHerbalife drops over 13% to $38.90
Subscribe for More Information
September 18, 2014
06:24 EDTAVPCiti defends recent downgrade of Avon Products
Citigroup says that following investor pushback, it is defending its September 8 downgrade of Avon Products to Neutral. The firm says it is comfortable with below consensus estimates given the recent strengthening of the U.S. dollar relative to several currencies. Citi adds that it has less confidence in Avon's turnaround following the departure of CFO Ross. It keeps a Neutral rating on the stock with a $15 price target.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use